ERYTECH Pharma

ERYTECH Pharma, founded in Lyon, France in 2004, is a clinical-stage biopharmaceutical company developing innovative therapies for rare cancers and orphan diseases. Leveraging its proprietary ERYCAPS® platform, ERYTECH has developed a portfolio of product candidates targeting markets with unmet medical needs, using the platform’s novel technology to encapsulate therapeutic substances within red blood cells. ERYTECH's initial focus was on developing products that target altered amino acid metabolism in cancer cells, thereby depriving them of the nutrients essential for their survival.